Early research (Phase 1)Study completedNCT01656265What this trial is testingStudy of ARQ 197 in Hepatocellular Carcinoma (HCC)Who this might be right forAdvanced Hepatocellular Carcinoma Kyowa Kirin Co., Ltd. 24
Not applicableLooking for participantsNCT06643000What this trial is testingEvaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal MetastasisWho this might be right forNon-small Cell Lung CancerLeptomeningeal MetastasisEGFR Gene Mutation Henan Cancer Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06814067What this trial is testingPhase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma HNSCC Fudan University 80
Not applicableStudy completedNCT00460356What this trial is testingGlycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesWho this might be right forCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+6 more Gynecologic Oncology Group 159
Early research (Phase 1)Study completedNCT00739453What this trial is testingDose-escalation Study of OSI-906 and Erlotinib (Tarceva®)Who this might be right forAdvanced Solid Tumors Astellas Pharma Inc 95
Early research (Phase 1)Study completedNCT00056537What this trial is testingABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic CancerWho this might be right forNon-Small-Cell Lung CarcinomaRenal Cell CarcinomaPancreatic Cancer Active Biotech AB 44
Early research (Phase 1)Study completedNCT02897375What this trial is testingPalbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsWho this might be right forSolid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more Emory University 71
Testing effectiveness (Phase 2)Study completedNCT00022477What this trial is testingBMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal CancerWho this might be right forColorectal Cancer University of Chicago 24
Testing effectiveness (Phase 2)Looking for participantsNCT06538857What this trial is testingCEB-01 in Locally Resectable Pancreatic CancerWho this might be right forPancreatic Carcinoma CEBIOTEX 39
Testing effectiveness (Phase 2)UnknownNCT01973101What this trial is testingNon-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.Who this might be right forPatients Diagnosed With Advanced Carcinoma of Uterine Cervix t Instituto do Cancer do Estado de São Paulo 120
Testing effectiveness (Phase 2)Study completedNCT00064012What this trial is testingBortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer University of Wisconsin, Madison 4
Testing effectiveness (Phase 2)Study completedNCT03463681What this trial is testingCaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinomaWho this might be right forMetastatic Renal Cell Carcinoma Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 49
Early research (Phase 1)Study completedNCT00626158What this trial is testingGemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary CancersWho this might be right forPancreatic CancerBiliary Cancer University of California, San Francisco 45
Not applicableUnknownNCT03090815What this trial is testingCirculating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung AdenocarcinomaWho this might be right forAdenocarcinoma of Lung (Disorder) The University of Hong Kong 100
Testing effectiveness (Phase 2)Ended earlyNCT01313390What this trial is testingEverolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer University College, London 4
Testing effectiveness (Phase 2)Looking for participantsNCT06412510What this trial is testingPrehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACTWho this might be right forOvarian CancerEpithelial Ovarian CancerPancreatic Adenocarcinoma Case Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT01601808What this trial is testingClinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic CarcinomaWho this might be right forPancreatic Cancer University of Liverpool 142
Large-scale testing (Phase 3)Looking for participantsNCT04749108What this trial is testingStudy Evaluating the Tailored Management of Locally-advanced Rectal CarcinomaWho this might be right forLocally Advanced Malignant NeoplasmRectal Carcinoma Institut du Cancer de Montpellier - Val d'Aurelle 1,075
Early research (Phase 1)Ended earlyNCT00492440What this trial is testingInterleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Cytheris SA 9
Large-scale testing (Phase 3)Study completedNCT01661790What this trial is testingIntrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung CancerWho this might be right forMalignant Pleural Effusion Chinese PLA General Hospital 72